1. Home
  2. IMNM vs BLDP Comparison

IMNM vs BLDP Comparison

Compare IMNM & BLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • BLDP
  • Stock Information
  • Founded
  • IMNM 2006
  • BLDP 1979
  • Country
  • IMNM United States
  • BLDP Canada
  • Employees
  • IMNM N/A
  • BLDP N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • BLDP Industrial Machinery/Components
  • Sector
  • IMNM Health Care
  • BLDP Energy
  • Exchange
  • IMNM Nasdaq
  • BLDP Nasdaq
  • Market Cap
  • IMNM 1.2B
  • BLDP 1.1B
  • IPO Year
  • IMNM 2020
  • BLDP 1995
  • Fundamental
  • Price
  • IMNM $18.12
  • BLDP $2.92
  • Analyst Decision
  • IMNM Strong Buy
  • BLDP Sell
  • Analyst Count
  • IMNM 8
  • BLDP 8
  • Target Price
  • IMNM $25.75
  • BLDP $2.07
  • AVG Volume (30 Days)
  • IMNM 1.4M
  • BLDP 6.6M
  • Earning Date
  • IMNM 11-06-2025
  • BLDP 11-13-2025
  • Dividend Yield
  • IMNM N/A
  • BLDP N/A
  • EPS Growth
  • IMNM N/A
  • BLDP N/A
  • EPS
  • IMNM N/A
  • BLDP N/A
  • Revenue
  • IMNM $9,679,000.00
  • BLDP $90,252,000.00
  • Revenue This Year
  • IMNM N/A
  • BLDP $28.67
  • Revenue Next Year
  • IMNM $85.36
  • BLDP $21.39
  • P/E Ratio
  • IMNM N/A
  • BLDP N/A
  • Revenue Growth
  • IMNM N/A
  • BLDP N/A
  • 52 Week Low
  • IMNM $5.15
  • BLDP $1.00
  • 52 Week High
  • IMNM $18.79
  • BLDP $4.10
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 64.32
  • BLDP 37.39
  • Support Level
  • IMNM $16.11
  • BLDP $3.21
  • Resistance Level
  • IMNM $17.94
  • BLDP $3.69
  • Average True Range (ATR)
  • IMNM 1.26
  • BLDP 0.27
  • MACD
  • IMNM 0.02
  • BLDP -0.09
  • Stochastic Oscillator
  • IMNM 86.56
  • BLDP 4.17

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.

Share on Social Networks: